2.50
3.85%
-0.10
Handel nachbörslich:
2.50
Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten
Puma Biotechnology rises on appeal of AstraZeneca Tagrisso patent dispute - MSN
Puma Biotech's patent suit sees mixed verdict - Investing.com
Is Puma Biotechnology (NASDAQ:PBYI) A Risky Investment? - Simply Wall St
Puma Biotechnology Inc [NASDAQ: PBYI] Sees Decrease in Stock Value - Knox Daily
Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - sharewise
Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Financial Analysis: Puma Biotechnology Inc (PBYI)’s Ratios Unveil Key Insights - The Dwinnex
Was there any good news for Puma Biotechnology Inc (PBYI) stock in the last session? - US Post News
Q1 2026 EPS Estimates for Puma Biotechnology, Inc. Boosted by Analyst (NASDAQ:PBYI) - MarketBeat
Zacks Research Analysts Decrease Earnings Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat
Market Momentum: Puma Biotechnology Inc (PBYI) Registers a 4.33 Increase, Closing at 2.65 - The Dwinnex
Puma Biotech confirms court ruling on patent invalidity, disagrees with verdict - MSN
Lacklustre Performance Is Driving Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 26% Price Drop - Simply Wall St
Puma Biotech patent claims partially invalidated in court - Investing.com
Puma Biotech patent claims partially invalidated in court By Investing.com - Investing.com India
Puma Biotech patent claims partially invalidated in court By Investing.com - Investing.com Australia
Puma Biotech confirms court ruling on patent dispute with AstraZeneca - Seeking Alpha
Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso - MSN
Post-Trade Analysis: Puma Biotechnology Inc (PBYI) Slides -24.79, Closing at 2.71 - The Dwinnex
Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso - Seeking Alpha
Puma Biotechnology, Inc. (NASDAQ:PBYI) Director Michael Patrick Miller Sells 23,358 Shares of Stock - Defense World
Puma Biotechnology, Inc. (NASDAQ:PBYI) Director Sells $81,519.42 in Stock - MarketBeat
Puma Biotechnology director sells over $81k in company stock - Investing.com
Puma Biotechnology director sells over $81k in company stock By Investing.com - Investing.com UK
Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - MarketBeat
Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - Defense World
Vanguard Group Inc. Reduces Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Sold by Vanguard Group Inc. - MarketBeat
Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye - Yahoo Finance
Puma Biotech prevails in patent suit against AstraZeneca - Investing.com
Puma Biotech prevails in patent suit against AstraZeneca - Investing.com India
Puma Biotech prevails in patent suit against AstraZeneca By Investing.com - Investing.com UK
Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com - Defense World
Following a 1.5% decline over last year, recent gains may please Puma Biotechnology, Inc. (NASDAQ:PBYI) institutional owners - Simply Wall St
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Puma Biotechnology (NASDAQ:PBYI) Upgraded by StockNews.com to "Strong-Buy" - MarketBeat
Citigroup upgrades Puma Biotechnology Inc (PBYI) stock to a Buy - Knox Daily
Puma Biotechnology (NASDAQ:PBYI) Issues Earnings Results - Defense World
HC Wainwright Reiterates Buy Rating for Puma Biotechnology (NASDAQ:PBYI) - Defense World
Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Puma Biotechnology (NASDAQ:PBYI) Releases Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report - Yahoo Finance
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Puma Biotechnology reported a total revenue reaching $47.1 million - Investing.com Canada
Earnings call: Puma Biotechnology reported a total revenue reaching $47.1 million - Investing.com UK
Lazard Asset Management LLC Acquires 48,520 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - MSN
Puma Biotechnology (NASDAQ:PBYI) Rating Reiterated by HC Wainwright - MarketBeat
Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - Yahoo Finance
Analyzing Pacira BioSciences (NASDAQ:PCRX) & Puma Biotechnology (NASDAQ:PBYI) - Defense World
Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - Zacks Investment Research
Zacks.com featured highlights Abercrombie & Fitch, Puma Biotechnology, Spotify and Oddity - Yahoo Finance
Puma Biotech: Q2 Earnings Snapshot - San Antonio Express-News
Puma Biotech: Q2 Earnings Snapshot - Thehour.com
Puma Biotechnology, Inc. (PBYI) Q2 2024 Earnings Call Transcript - Seeking Alpha
Puma Biotech: Q2 Earnings Snapshot - San Francisco Chronicle
Puma Biotechnology Reports Second Quarter Financial Results - sharewise
Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Puma Biotech: Q2 Earnings Snapshot - The Washington Post
Puma Biotech: Q2 Earnings Snapshot - Santa Maria Times
Puma Biotechnology Reports Second Quarter Financial Results - Business Wire
Puma Biotechnology Reports Second Quarter Financial Results - StockTitan
Puma Biotechnology Inc [PBYI] President and CEO makes an insider sale of 21,920 shares worth $81128.0. - Knox Daily
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Acquired by O Shaughnessy Asset Management LLC - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):